tert-butyl 3-[(1-phenylethyl)amino]propanoate, 95.0%, 2g

2-Amino-2-cyclopropylacetic acid, 98%, 5g

Long working distance plan Fluarex 4x/0.13 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

2-(4-Methoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane, 97%, 5g

Midecamycin, >98.0%, 1g

(S)-3-(3-fluorophenyl)-2-hydroxypropanoic acid, 98%, 100mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(3-((tert-butoxycarbonyl)amino)propyl)glycine, 97%, 5g

4-Amino-6-chloropyridin-3-ol, 95.0%, 100mg

Dexamethasone acetate, 1g

2-Methoxy-1-nitro-4-(trifluoromethyl)benzene, 98%, 25g

6-Methylpyrimidine-4-carboxylic acid, 95.0%, 100mg

1-(8-Bromoquinolin-2-yl)ethanone, 1g

2',6'-DIMETHYL-4'-(3-(METHYLSULFONYL)PROPOXY)-[1,1'-BIPHENYL]-3-CARBALDEHYDE, 95.0%, 250mg